Skip to main content
OpenTrials
Completed

NCT Number: NCT02764554

Post-Marketing Surveillance of Lenvima in Korean Patients

The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Differentiated Thyroid Carcinoma (DTC) Neoplasm Metastasis Neoplasms Neoplastic Processes Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Eisai Trial Site #18, Anyang, Gyeongji-do, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants who meet the following criteria will be eligible for inclusion in the study:

  • Participants with approved indication for lenvatinib in Korea
  • Participants who have written consent for use of personal and medical information for the study purpose

Exclusion criteria

Investigators will refer to approved indications and contraindications regarding exclusion criteria

Treatment and study plan

Primary outcomes

  1. Number of Participants with Adverse Events, Serious Adverse Events, and Adverse Drug Reactions

    Time frame: Up to 1 year

Sponsors and collaborators

Lead sponsor

Eisai Korea Inc.

Industry

Registry information

Important dates

Study start
2016
Primary completion
2021
Study completion
2021
First posted
May 6, 2016
Registry last updated
Oct 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.